UK markets closed

4D pharma plc (DDDD.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
34.65+1.55 (+4.68%)
At close: 04:35PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
522
522
534
211
0
Operating expenses
Research development
19,818
19,818
22,041
26,512
24,908
Selling general and administrative
4,906
4,906
4,096
1,572
2,239
Total operating expenses
27,051
27,051
31,075
30,825
29,119
Operating income or loss
-26,529
-26,529
-30,541
-30,614
-29,119
Interest expense
610
610
173
514
348
Income before tax
-57,465
-57,465
-30,346
-29,426
-28,437
Income tax expense
-3,505
-3,505
-4,383
-5,360
-4,747
Income from continuing operations
-53,960
-53,960
-25,963
-24,066
-23,690
Net income
-53,960
-53,960
-25,963
-24,066
-23,690
Net income available to common shareholders
-53,960
-53,960
-25,963
-24,066
-23,690
Basic EPS
-
-
-0.23
-0.37
-0.36
Diluted EPS
-
-
-0.23
-0.37
-0.36
Basic average shares
-
-
113,852
65,494
65,494
Diluted average shares
-
-
113,852
65,494
65,494
EBITDA
-
-55,879
-28,967
-27,631
-26,888